Introduction of an RS1 mutation causative variant consistent with identified XLRS patient using CRISPR/Cas9 technology in normal iPSC.

导出 LinkOut

翻译打印收藏纠错

作者： Xihao,Sun ^[1] ; Shengru,Mao ^[2] ; Yuqin,Liang ^[1] ; Chunwen,Duan ^[2] ; Zekai,Cui ^[1] ; Jianing,Gu ^[1] ; Bing,Jiang ^[3] ; Chengcheng,Ding ^[1] ; Jiansu,Chen ^[4] ; Shibo,Tang ^[5]

作者单位： Aier Eye Institute, Changsha, Hunan, China. ^[1] Aier Eye Institute, Changsha, Hunan, China; The Second Xiangya Hospital, Central South University, Changsha, Hunan, China. ^[2] The Second Xiangya Hospital, Central South University, Changsha, Hunan, China. ^[3] Aier Eye Institute, Changsha, Hunan, China; Key Laboratory of Regenerative Medicine, Ministry of Education, Jinan University, Guangzhou, Guangdong, China. ^[4] Aier Eye Institute, Changsha, Hunan, China; Guangzhou Aier Eye Hospital, Guangzhou, Guangdong, China. ^[5]

主题词诱导多能干细胞(Induced Pluripotent Stem Cells);人类(Humans);视网膜劈裂症(Retinoschisis);眼蛋白质类(Eye Proteins);男(雄)性(Male);突变(Mutation);细胞系(Cell Line)

DOI 10.1016/j.scr.2024.103549

PMID 39232357

发布时间 2024-12-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Stem cell research

2024年81卷

103549页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Introduction of an RS1 mutation causative variant consistent with identified XLRS patient using CRISPR/Cas9 technology in normal iPSC.

Stem cell research

相似文献

Stem cell research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Introduction of an RS1 mutation causative variant consistent with identified XLRS patient using CRISPR/Cas9 technology in normal iPSC.

Stem cell research

相似文献

Stem cell research

相关期刊

检索历史清除